Pruritus in HIV-infected patients in the era of combination antiretroviral therapy: A study of its prevalence and causes

International Journal of STD and AIDS

Volumn 23, Issue 4, 2012, Pages 255-257

  Blanes, M ^a   Belinchon I ^b   Portilla, J ^b   Betlloch, I ^b   Reus, S ^b   Sanchez Paya J ^b  

^a HOSPITAL MARINA BAIXA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

Antiretroviral therapy; ART; Dermatoses; HIV; Pruritus

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; DERMATITIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; PRURITUS; SPAIN; SYMPTOM; TINEA PEDIS; VIRUS LOAD; XEROSIS;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; PREVALENCE; PRURITUS; SKIN DISEASES; SPAIN; VIRAL LOAD;

EID: 84861555609     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2009.009189     Document Type: Article

References (11)

1. Mouton Y, Alfandari S, Valette M, et al. Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres. Federation National des Centres de Lutte contre le SIDA. AIDS 1997;11:F101-05
2. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338:853-60
3. Singh F, Rudikoff D. HIV-associated pruritus: etiology and management. Am J Clin Dermatol 2003;4:177-88
4. Muñoz Pérez MA. Manifestaciones cuta ́neomucosas en pacientes VIH positivos: Incidencia, correlación clínica, inmunológica y dermatopatológica. Estudio prospectivo de 1161 pacientes. Actas Dermatosifiliogr 1999;90:11-20
5. Spira R, Mignard M, Doutre MS, Morlat P, Dabis F. Prevalence of cutaneous disorders in a population of HIV-infected patients. Arch Dermatol 1998;134:1208-12
6. Zancanaro PC, McGirt LY, Mamelak AJ, Nguyen RH, Martins CR. Cutaneous manifestations of HIV in the era of highly active antiretroviral therapy: an institutional urban clinic experience. J Am Acad Dermatol 2006;54:581-88
7. Milazzo F, Piconi S, Trabattoni D, et al. Intractable pruritus in HIV infection: immunologic characterization. Allergy 1999;54:266-72
8. Rodwell GE, Berger TG. Pruritus and cutaneous inflammatory conditions in HIV disease. Clin Dermatol 2000;18:479-84
9. Cohen AJ, Steigbigel RT. Eosinophilia in patients infected with human immunodeficiency virus. J Infect Dis 1996;174:615-18
10. Calista D, Morri M, Stagno A, Boschini A. Changing morbidity of cutaneous diseases in patients with HIV after the introduction of highly active antiretroviral therapy including a protease inhibitor. Am J Clin Dermatol 2002;3:59-62
11. Gelfand JM, Rudikoff D. Evaluation and treatment of itching in HIV-infected patients. Mt Sinai J Med 2001;68:298-308